10.1007/s12282-016-0730-3 - Post-relapse survival in patients wit...

This document has been corrected

Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

10.1007/s12282-016-0730-3

Published Online: 2016-09-15

Journal: Breast Cancer•Publisher: Springer Science and Business Media LLC

Authors: •Akiko Ogiya•Hiroko Yamashita•Hiroyuki Yasojima•Kieko Yamazaki•Masato Takahashi•Mitsuchika Hosoda•Naoko Ishida•Nobumoto Tomioka•Norikazu Masuda•Rie Horii•Tadahiko Shien•Tomofumi Osako•Touko Inao•Yoshiya Horimoto•Yuichiro Miyoshi•Yumi Endo

This document has been corrected

Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

10.1007/s12282-016-0730-3

Published Online: 2016-09-15

Journal: Breast Cancer

Authors: Akiko Ogiya•Hiroko Yamashita•Hiroyuki Yasojima•Kieko Yamazaki•Masato Takahashi•Mitsuchika Hosoda•Naoko Ishida•Nobumoto Tomioka•Norikazu Masuda•Rie Horii•Tadahiko Shien•Tomofumi Osako•Touko Inao•Yoshiya Horimoto•Yuichiro Miyoshi•Yumi Endo

NOW

2017-04-04•Correction

Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

10.1007/s12282-017-0771-2

* information provided by CrossRef

2017-04-04•Correction

10.1007/s12282-017-0771-2

* information provided by CrossRef

2016-09-15•Published

2017-04-04•Correction

Erratum to: Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

10.1007/s12282-017-0771-2

* information provided by CrossRef

This document has been corrected

Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer

10.1007/s12282-016-0730-3

Published Online: 2016-09-15

Journal: Breast Cancer•Publisher: Springer Science and Business Media LLC